Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

21.97
Delayed Data
As of Jun 24
 -1.63 / -6.91%
Today’s Change
19.59
Today|||52-Week Range
65.34
-64.52%
Year-to-Date
These 5 Biotech Stocks Are Ridiculously Cheap
Jun 21 / MotleyFool.com - Paid Partner Content
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Jun 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close23.60
Today’s open22.35
Day’s range21.93 - 23.46
Volume2,528,122
Average volume (3 months)2,339,775
Market cap$2.9B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-100.62%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book14.15

Competitors

 Today’s
change
Today’s
% change
PRAHPRA Health Sciences ...-1.88-4.28%
PRXLPAREXEL Internationa...-1.20-1.98%
INCRINC Research Holding...-0.85-2.16%
NKTRNektar Therapeutics-1.16-7.46%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts

Partner Offers

Search for Jobs